11-72816815-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_033388.2(ATG16L2):āc.206A>Gā(p.His69Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000253 in 1,614,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_033388.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ATG16L2 | NM_033388.2 | c.206A>G | p.His69Arg | missense_variant | 2/18 | ENST00000321297.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATG16L2 | ENST00000321297.10 | c.206A>G | p.His69Arg | missense_variant | 2/18 | 1 | NM_033388.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152168Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000179 AC: 45AN: 251406Hom.: 0 AF XY: 0.000191 AC XY: 26AN XY: 135890
GnomAD4 exome AF: 0.000261 AC: 382AN: 1461784Hom.: 0 Cov.: 31 AF XY: 0.000286 AC XY: 208AN XY: 727192
GnomAD4 genome AF: 0.000171 AC: 26AN: 152286Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74460
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 18, 2023 | The c.206A>G (p.H69R) alteration is located in exon 2 (coding exon 2) of the ATG16L2 gene. This alteration results from a A to G substitution at nucleotide position 206, causing the histidine (H) at amino acid position 69 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at